|
ZNF410 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.735600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.394390E-01 |
| Normal-vs-Stage2 |
6.184600E-01 |
| Normal-vs-Stage3 |
1.632490E-02 |
| Normal-vs-Stage4 |
6.577400E-03 |
| Stage1-vs-Stage2 |
5.814800E-01 |
| Stage1-vs-Stage3 |
1.582050E-01 |
| Stage1-vs-Stage4 |
9.143800E-02 |
| Stage2-vs-Stage3 |
1.531160E-01 |
| Stage2-vs-Stage4 |
7.661900E-02 |
| Stage3-vs-Stage4 |
5.732400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.591900E-02 |
| Normal-vs-AfricanAmerican |
3.941000E-01 |
| Normal-vs-Asian |
7.994000E-01 |
| Caucasian-vs-AfricanAmerican |
7.168600E-01 |
| Caucasian-vs-Asian |
9.629900E-02 |
| AfricanAmerican-vs-Asian |
5.237600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.298200E-02 |
| Normal-vs-Female |
8.406100E-02 |
| Male-vs-Female |
3.859000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.048600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.799600E-02 |
| Normal-vs-Age(61-80Yrs) |
9.338000E-03 |
| Normal-vs-Age(81-100Yrs) |
1.174380E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.866200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.746400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.414000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.262600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.003400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.216000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.337900E-02 |
| Classical-VS-Follicular |
4.674400E-02 |
| Classical-VS-Other |
2.181200E-01 |
| Classical-VS-Normal |
4.175400E-01 |
| Tall-VS-Follicular |
6.316200E-01 |
| Tall-VS-Other |
8.948200E-01 |
| Tall-VS-Normal |
1.000030E-02 |
| Follicular-VS-Other |
7.480800E-01 |
| Follicular-VS-Normal |
2.205700E-02 |
| Other-VS-Normal |
9.466500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.312300E-02 |
| Normal-vs-N1 |
1.337280E-03 |
| N0-vs-N1 |
4.232300E-02 |
|
|
